Last reviewed · How we verify
NCT05201456: LVE
LithoVue Elite Registry
trial testing LithoVue Elite System in Kidney Stone. Withdrawn.
1 April 2023
Quick facts
| Lead sponsor | Boston Scientific Corporation |
|---|---|
| Status | Withdrawn |
| Study type | OBSERVATIONAL |
| Start date | 1 April 2023 |
| Primary completion | 1 April 2023 |
| Estimated completion | 1 December 2023 |
Drugs / interventions tested
- LithoVue Elite System
Conditions studied
- Kidney Stone — all drugs for Kidney Stone →
- Urolithiasis — all drugs for Urolithiasis →
Sponsor
Boston Scientific Corporation — full company profile →
Who can join
Eligibility, any sex, with Kidney Stone or Urolithiasis. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
To obtain postmarket safety and efficacy data on Boston Scientific LithoVue™ Elite System.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
Single use flexible ureteroscopes: Current status and future directions.
Juliebø-Jones P, Ventimiglia E, Somani BK, Æsøy MS, et al · · 2023 · cited 15× · PMID 37818020 · DOI 10.1002/bco2.265
Verify or expand the search:
- PubMed search for NCT05201456
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Kidney Stone
Currently open trials in the same condition.
- NCT06944223 — Oxalate and Citrate in Humans - Response to Citrate · NA · recruiting
- NCT07071948 — A Single-Center Clinical Study on the Efficacy and Safety of VISOR · NA · recruiting
- NCT06576661 — Evaluation of the LithoVue Elite Ureteroscope With Intra-Renal Pressure Monitoring Technology: Examination of Surgeon Be · NA · recruiting
- NCT06210009 — Effect of a DASH-Style Diet on Urinary Risk Factors for Kidney Stone Disease · NA · recruiting
- NCT07238803 — Outcomes of Using FANS With FURS in TTT of Lower Calyceal Stones. · NA · recruiting
Other Boston Scientific Corporation trials
Trials by the same sponsor.
- NCT07458243 — Registry of ENROUTE NPS in Conjunction With Carotid WALLSTENT · not yet recruiting
- NCT07458217 — Combined CM and STN Stimulation for Motor Epilepsy · NA · not yet recruiting
- NCT07276815 — OverStitch NXT Endoscopic Suture System · NA · not yet recruiting
- NCT07353710 — A Study on the Acquisition of 2D ICE Images With the CHORUS IDx System in Subjects Undergoing an Ablation Procedure · NA · not yet recruiting
- NCT07195708 — Orbera365 Intragastric Balloon System (Abbreviated as'Orbera365') · NA · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05201456 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Boston Scientific Corporation
- Last refreshed: 18 December 2023
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05201456.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing